We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Innovaderma Plc | LSE:IDP | London | Ordinary Share | GB00BT9PTW34 | ORD EUR0.10 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 29.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
13/1/2020 15:48 | Might get a holdings rns | anony mous | |
13/1/2020 13:19 | Yet again this share is proving a cash cow to shorters .This share just keeps giving and giving to these people.(with a little bit of help !)60p now - 50p next stop before the next leg up? | teddy boy1 | |
13/1/2020 12:34 | Reiteration of £15.8 million turnover target. | boonboon | |
13/1/2020 12:00 | Who knows...to buy a patent?to develop something??? | costax1654x | |
13/1/2020 10:37 | The launch of the new product category will be very interesting given that potential market and that it is not included within the current financial forecasts either. | matt | |
11/1/2020 14:57 | Hc prob chuckling to himself | wton1 | |
11/1/2020 14:56 | A placing for what? They have good cash reserves. | jonny_five111 | |
11/1/2020 07:22 | Wonder if is a Placing (forward selling?) | costax1654x | |
11/1/2020 07:19 | 53...can not get lower than that!on charts | costax1654x | |
10/1/2020 20:28 | How low will the share price be "taken " this time ? 50p Sounds like a nice round figure and will ensure yet another very nice payday for our "manlipulators" | teddy boy1 | |
10/1/2020 13:46 | IDP mkt cap just 9mWhat is the year profit estimate | anony mous | |
10/1/2020 13:33 | So, Superdry estimates profits will be between 0 and 10 million.There mkt cap is about 331 million pounds.IDP is very undervalued. | anony mous | |
10/1/2020 13:20 | Lolly. About research before investing, absolutely, I agree with you, I am surprised how many things I missed, not the first time either, I often sell within a few days of buying. Generally I steer clear of v small cap plcs and plc with over-reliance on a single/few product(s) or few customers (boots/superdrug) in this case. DTC mitigates in my not so well informed opinion. Balance sheet ok, cash flow ok considering launch/stocking stage for three categories, sales figures have a good record for a decent-ish length of time, in, what is and has been, a generally difficult environment for fmcg. That points to pretty successful marketing and broad managerial competence. Think share price discount prob warranted until several years of solid trading, more product launches giving some balance to the portfolio. Figure themselves are a positive. Fashion/fad, driven I agree also, productive pipeline helps but another risk, would prefer to see successful long term brand building. What is the opinion on the NED's here? Any take-over interest from larger fmcg plc? Thanks for helpful replies all | pixelrobox | |
10/1/2020 12:10 | Stopped at a Superdrug to check on product positioning. SkinnyTan well placed with large range. The branch I was in only had 2 of 3 Roots products in stock on a lower shelf. I do wonder about the market and packaging of Roots given colour wise it is similar to Head & Shoulders but twice the price. The latter had prime top two shelves space for their full range. Most of the competitor hair products are in exciting colourful packaging. Roots, H&S and Superdrug own brand anti-dandruff the exceptions. | matt | |
10/1/2020 09:18 | They did say sales were up 71%. | boonboon | |
10/1/2020 09:13 | Disappointing that there was absolutely no mention of Prolong progress in the RNS - there must be nothing happening there? | carlo sartori | |
10/1/2020 08:28 | pixelrobox If you haven't already, I would strongly recommend looking at the Finncap notes. They give a lot of useful info of the segmentation by geography and product. (I think it's all there in the AR anyway, but Finncap make it easier to review imho) | kazoom | |
09/1/2020 17:40 | Direct to investor kaka | wton1 | |
09/1/2020 17:40 | I am going to have the final word: kaka This is kaka | wton1 | |
09/1/2020 17:29 | pixelrobox - DTC data is certainly valuable. You only have to look at the likes of Ebay & Amazon to see where it can take you. But only time will tell whether IDP is valuing its customer list conservatively enough. After all, their products are to an extent fashion/fad driven. And trends can change quickly. That said, management seems nimble & innovative, with plenty of NPD going on. Assuming H2 grows at a similar rate to H1, a sharp upward re-rating wouldn't surprise me. And as a reasonably long term holder already, I'd say it's kind of overdue! BTW, you ask a number of pertinent questions. I'm just slightly surprised you didn't seek answers BEFORE investing! | lord loads of lolly | |
09/1/2020 16:18 | Thx boon for the info, more the better. My v uneducated opinion is that DTC data should be valuable and, as you mention, cross selling, managing the brand perception directly too. From employee numbers and info on this board I gather this is a straight marketing, product concept development plc, rather than producer/manufacture There was some mention of self serving executives on this board, anything more on that? governance, impression of CE etc? | pixelrobox | |
09/1/2020 14:47 | I am fairly new to this stock, followed on/off for 6-9 months or so, just bought a small holding . Seems v volatile and stock movements odd given the trading. Been over the pl, cash flow and balance sheet several times, seems ok. A couple of negatives that I did not notice until after my purchase (sharpens the mind). There were some questions on this board re capitalizing customer acquisition. Whoever raised it, it is a good point to make, note 12 of fy results showed 'customer lists' at just over £2.1m, not particularly high, something to watch as, if growth turns south, obvious impairment. Like the Notes section of results, helped to segment sales. Skinny Tan really does dominate, kind of explains the risks discount IDP trades at, although fy19 saw excellent growth in the other 3 segments, it is nonetheless disappointing to read that Roots growth was below expectations in the trading statement. As usual this is a matter of interpretation, does that mean flat, fall or growth that did not meet expectations. Would like to see profits and margins segmented in the result, margins too, it is quite possible that ST accounts for all the profit at this stage | pixelrobox |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions